← Evidence map

ReviewDrug safety2003

A benefit-risk assessment of sibutramine in the management of obesity.

Enzo Nisoli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2003

…

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled itcites it

A benefit-risk assessment of sibutramine in the management of obesity. | Socratic